JC
NVO

JB Capital’s Novo Nordisk NVO Stock Holding History

JB Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,574
Closed -$478K – 210
2022
Q2 		$478K Buy
8,574
+246
+3% +$13.7K 0.05% 162
2022
Q1 		$463K Sell
8,328
-1,396
-14% -$71.6K 0.05% 171
2021
Q4 		$545K Buy
9,724
+22
+0.2% +$1.19K 0.05% 158
2021
Q3 		$466K Buy
+9,702
New +$469K 0.06% 177

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

JB Capital's NVO Position: Q3 2022 in Review

JB Capital sold out of Novo Nordisk (NVO) in Q3 2022, closing a stake of 8,574 shares — an estimated $478K sold.

JB Capital first reported a position in NVO in Q3 2021 and held it in 4 quarters. The position peaked at $545K in Q4 2021. 907 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

  • JB Capital reported no remaining Novo Nordisk position as of Q3 2022 after selling out during the quarter.
  • JB Capital sold 8,574 Novo Nordisk shares in Q3 2022, an estimated $478K.
  • JB Capital first reported a position in Novo Nordisk in Q3 2021 and held it in 4 quarters.
  • JB Capital's Novo Nordisk position peaked at $545K in Q4 2021.
  • 907 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on JB Capital's 13F filing for Q3 2022, filed 14 Oct 2022.